ERBB2 and gastric cancer: The National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for GC have incorporated genetic biomarkers for the complex clinical management of patients with GC (NCCN, 2018), and the statuses of MMR protein expression, HER2 immunohistochemical staining, and PD-L1 expression have emerged as biomarkers.